ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
Tác giả chính: | R.T. Saygitov |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
"Paediatrician" Publishers LLC
2008-08-01
|
Loạt: | Вопросы современной педиатрии |
Truy cập trực tuyến: | https://vsp.spr-journal.ru/jour/article/view/1441 |
Những quyển sách tương tự
-
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
Bằng: R.T. Saygitov
Được phát hành: (2008-01-01) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
Bằng: Cardile S, et al.
Được phát hành: (2012-02-01) -
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
Bằng: Yu. V. Yevsyutina
Được phát hành: (2018-08-01) -
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
Bằng: Gold Benjamin D, et al.
Được phát hành: (2009-11-01) -
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
Bằng: Roy C Orlando, et al.
Được phát hành: (2010-09-01)